Cytiva, a global leader in life sciences and bioprocessing technologies under the Danaher Corporation umbrella, has announced the appointment of Valérie Marjollet as President of its Resins, Filtration, and Cell Culture Media business.

Bringing extensive leadership experience and deep industry expertise, Marjollet will oversee one of Cytiva’s fastest-growing portfolios—spanning bioprocess resins, advanced filtration technologies, and cell culture media solutions that are foundational to biologics development and manufacturing.

Commenting on the appointment, Christopher Riley, CEO of Cytiva and Executive Vice President of Danaher, posted on LinkedIn

“We are thrilled to welcome Valérie Marjollet to Cytiva. Valérie brings a wealth of experience, knowledge, and expertise to her role. Over the past 18 months, I’ve had the opportunity to get really close to this business, and it’s an incredible team full of talented people. I’m confident Valérie will help us evolve and accelerate growth in this area.”

The appointment underscores Cytiva’s continued focus on advancing bioprocessing innovation and strengthening its global leadership in life sciences tools and solutions.

Marjollet will lead efforts to expand Cytiva’s technology footprint and customer support across biomanufacturing markets worldwide, furthering the company’s mission to enable customers to accelerate the development and delivery of life-changing therapies.